Solution to improve supply chain integrity

Oracle announces the availability of Oracle Pedigree and Serialization Manager, an integrated mass-serialization and pedigree application designed specifically to improve supply chain integrity in the pharmaceutical industry.

The solution helps pharmaceutical manufacturers facilitate compliance with emerging electronic pedigree (ePedigree) initiatives and regulatory requirements, reduce business and reputational risk associated with the rising incidence of drug counterfeiting and product diversion while extending value across the pharmaceutical supply chain.

It generates, stores, transmits and authenticates drug product serial data and ePedigree data as pharmaceutical products move across the supply chain. This facilitates counterfeit threat identification and streamlines compliance. In addition, integrated analytics within the solution provide pharmaceutical manufacturers with expanded insight into possible threats.

Pharmaceutical companies can use this solution to improve the efficiency and accuracy of returns management and reduce associated losses. Non-repudiation capabilities automate assessment and reconciliation of products returned against products shipped, helping to reduce write offs.

In addition, this software helps pharmaceutical companies maintain stronger channel integrity by enabling them to reduce product diversions, such as from lower reimbursement locations to higher reimbursement locations. It also can help reduce revenue leakage by helping to improve scrutiny of chargeback rebates paid out to wholesalers.

Built on an open standards-based Service-Oriented Architecture (SOA) and Oracle Fusion Middleware applications, Oracle Pedigree and Serialization Manager is built to integrate with existing Oracle and third-party systems for manufacturing, packaging and shipping and receiving.